Statistics

Statistics

Total Visits

Views
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial) 43

Total Visits Per Month

July 2021 August 2021 September 2021 October 2021 November 2021 December 2021 January 2022
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial) 4 3 4 2 4 4 4

File Visits

Views
Ahmadzadehfar_Prior_2020.pdf 13

Top country views

Views
United States 14
United Kingdom 7
South Africa 7
Czech Republic 2
Germany 2
China 1
Sweden 1

Top cities views

Views
Bryanston 7
Oakland 5
Southend 5
Ann Arbor 2
Cambridge 1
Falls Church 1
Fremont 1
Fuzhou 1
Houston 1
Jacksonville 1